General
Preferred name
HESPERETIN
Synonyms
(-)-hesperetin ()
FEMA NO. 4313 ()
NSC-57654 ()
Eriodictyol 4'-monomethyl ether ()
Hesperitin ()
P&D ID
PD001966
CAS
520-33-2
41001-90-5
Tags
available
natural product
drug
Drug indication
High blood cholesterol level
Drug Status
approved
investigational
experimental
Max Phase
0.5
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Hesperetin is a natural flavonoid. It has antibacterial activity against Gram-negative H. pylori .
(GtoPdb)
DESCRIPTION
Hesperetin is a natural flavanone, and acts as a potent and broad-spectrum inhibitor against human UGT activity. Hesperetin regulates apoptosis.
PRICE
29
DESCRIPTION
Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
4
Organisms
0
Compound Sets
15
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
46
Molecular Weight
302.08
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
2.52
TPSA
96.22
Fraction CSP3
0.19
Chiral centers
1.0
Largest ring
6.0
QED
0.79
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Apoptosis
Autophagy
GPCR/G protein
MAPK
Neuroscience
Stem Cells
Immunology/Inflammation
MAPK/ERK Pathway
Metabolic Enzyme/Protease
Member status
member
MOA
Lipid Lowering Agents
Antioxidants
Triglyceride Lowering Agents
Cytochrome P450 CYP1B1 Inhibitors
TRPM3 Antagonists
ACAT inhibitor
Target
DGAT1, MTTP, SOAT1, SOAT2
Bcl-2 Family
NF-κB
p38 MAPK
Reactive Oxygen Species (ROS)
Histamine Receptor,TGF-beta/Smad
HT
TGFβ
Therapeutic Class
Anticholesteremic Agents
Source data

